创新药多元支付生态迈入支付+服务融合发展阶段

新华财经
Oct 15

新华财经上海10月15日电(记者胡洁菲)中国创新药发展正迎来多方机遇。一方面,中国创新药BD交易正进入密集收获期。据不完全统计,2025年上半年我国创新药对外授权交易总金额近660亿美元,超过2024年全年的519亿美元,BD的爆发已成为中国创新药业绩增长的一大“加速器”;另一方面,商业健康险对创新药的支持迎来顶层政策的多方护航,9月30日,国家金融监督管理总局对外发布《关于推动健康保险高质量发展...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10